In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI), the worldwide peptide therapeutics market currently for peptide therapies is estimated to be worth US$ 38.0 billion in 2023 and US$ 106.0 billion in 2033, growing at a remarkable CAGR of 10.8% from 2023 to 2033.Pepti.
The Peptide Therapeutics Market is estimated to be worth US$ 38.0 billion in 2023 and US$ 106.0 billion in 2033, growing at a remarkable CAGR of 10.8% from 2023 to 2033.The global Peptide Therapeutics Market is projected to reach a valuation of US$ 47 Bn in 2025, with sales growing at a prolific CAGR of 11% from 202.
[220 Pages Report] The global peptide therapeutics market was valued at US$ 25.6 Bn in 2021, and is expected to exhibit a healthy CAGR of 11% during the forecast period (2022-2025).Peptide therapeutics are witnessing substantial demand, owing to increasing application in the treatment of various chronic disease such.
[220 Pages Report] The global peptide therapeutics market was valued at US$ 25.6 Bn in 2021, and is expected to exhibit a healthy CAGR of 11% during the forecast period (2022-2025).Peptide therapeutics are witnessing substantial demand, owing to increasing application in the treatment of various chronic disease such.